Anti-CCR9 Chimeric Antigen Receptor T cells for T Cell Acute Lymphoblastic Leukemia. Maciocia PM, Wawrzyniecka PA, Maciocia NC, Burley A, et al. Blood 2022 May 4. pii: 485152. doi: 10.1182/blood.2021013648.

Read + Share

Amedeo Smart

Independent Medical Education

Maciocia PM, Wawrzyniecka PA, Maciocia NC, Burley A, et al. Anti-CCR9 Chimeric Antigen Receptor T cells for T Cell Acute Lymphoblastic Leukemia. Blood 2022 May 4. pii: 485152. doi: 10.1182/blood.2021013648.
PMID: 35507686